BioSpace News Archive

TFF Pharmaceuticals to Present at the H.C. Wainwright 22 nd Annual Global Investment Conference Corporate presentation and live webcast scheduled for Monday, September 14, 2020 at 4:00 PM EDT AUSTIN, Texas--( BUSINESS WIRE )-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, has be

Optikos Corporation announced today the Company has expanded its ISO certification to include ISO 13485:2016 , indicating that the Optikos Quality Management System meets the most current regulatory requirements specific to the design, manufacture, and distribution of medical devices. Optikos is a leading provider of both optical engineering and volume manufacturing services, and standard and custom products th

Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, announced today the presentation of positive safety and efficacy results from the pivotal Phase 3 study in adults of AR19, its investigational immediate-release, amphetamine sulfate capsule for the treatment of attention-deficit/hyperactivity disorder (ADHD

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the addition of state-of-the-art cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA.

United Health Products, Inc. (OTCPK: UEEC, “UHP”) today announced that it has uploaded the full results of its Human Trial study, Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting, to the ClinicalTrials.gov website; these results are expected to be made available to the public within 7-14 days.

RedShift BioAnalytics, Inc. (RedShiftBio) announced its award winning AQS3™pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in India.

NYU Long Island School of Medicine, NYU Langone Health, and NYU Grossman School of Medicine Collaborate on Protocols for Worldwide Adaptation in Urban Settings

Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based pharmacogenetics tests.

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to be presenting at the following upcoming virtual investor conferences:

Cynosure announced today that Anne Gates, former President at MGA Entertainment, the world’s largest private toy company, and Executive Vice President and CFO of The Walt Disney Company’s Consumer Products Division, has been appointed to its board of directors and will chair the company’s audit committee.